| Development and validation of a deep learning-based model using computed tomography imaging for predicting disease severity of coronavirus disease 2019 L Xiao, P Li, F Sun, Y Zhang, C Xu, H Zhu, FQ Cai, YL He, WF Zhang, ... Frontiers in bioengineering and biotechnology 8, 898, 2020 | 78 | 2020 |
| UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway W Hu, L Xiao, C Cao, S Hua, D Wu Oncotarget 7 (12), 15161, 2016 | 71 | 2016 |
| Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019 L Xiao, WF Zhang, M Gong, Y Zhang, L Chen, H Zhu, C Hu, P Kang, L Liu, ... EBioMedicine 57, 2020 | 46 | 2020 |
| Radiomics-based nomogram using CT imaging for noninvasive preoperative prediction of early recurrence in patients with hepatocellular carcinoma HB Zhu, ZY Zheng, H Zhao, J Zhang, H Zhu, YH Li, ZY Dong, LS Xiao, ... Diagnostic and Interventional Radiology 26 (5), 411, 2020 | 31 | 2020 |
| Chromobox homolog 8 (CBX8) Interacts with Y-Box binding protein 1 (YBX1) to promote cellular proliferation in hepatocellular carcinoma cells L Xiao, Z Zhou, W Li, J Peng, Q Sun, H Zhu, Y Song, JL Hou, J Sun, ... Aging (Albany NY) 11 (17), 7123, 2019 | 19 | 2019 |
| Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective … L Xiao, R Li, H Cui, C Hong, C Huang, Q Li, C Hu, Z Dong, H Zhu, L Liu BMC cancer 22 (1), 737, 2022 | 15 | 2022 |
| Increased mediator complex subunit 15 expression is associated with poor prognosis in hepatocellular carcinoma K Wang, C Duan, X Zou, Y Song, W Li, L Xiao, J Peng, L Yao, Q Long, ... Oncology letters 15 (4), 4303-4313, 2018 | 12 | 2018 |
| Effect of hypertension on outcomes of patients with COVID-19 HU Chengyi, X Lushan, Z Hongbo, Y ZHANG, W ZHANG, L Li, Z Hong Journal of Southern Medical University 40 (11), 1537, 2020 | 11 | 2020 |
| Lung metastasis and lymph node metastasis are risk factors for hyperprogressive disease in primary liver cancer patients treated with immune checkpoint inhibitors LS Xiao, QM Li, CY Hu, H Cui, C Hong, CY Huang, RN Li, ZY Dong, ... Annals of Palliative Medicine 10 (11), 112441254-112411254, 2021 | 9 | 2021 |
| A somatic mutation signature predicts the best overall response to anti-programmed cell death protein-1 treatment in epidermal growth factor receptor/anaplastic lymphoma kinase … J Peng, L Xiao, D Zou, L Han Frontiers in Medicine 9, 808378, 2022 | 8 | 2022 |
| Correlation between local air temperature and the COVID-19 pandemic in Hubei, China C Hu, L Xiao, H Zhu, H Zhu, L Liu Frontiers in Public Health 8, 604870, 2021 | 8 | 2021 |
| Nuclear division cycle 80 complex is associated with malignancy and predicts poor survival of hepatocellular carcinoma X Chen, W Li, L Xiao, L Liu International Journal of Clinical and Experimental Pathology 12 (4), 1233, 2019 | 8 | 2019 |
| Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors LS Xiao, CY Hu, H Cui, RN Li, C Hong, QM Li, CY Huang, ZY Dong, ... Cancer Medicine 11 (24), 4880-4888, 2022 | 7 | 2022 |
| Potential predictive value of JAK2 expression for pan-cancer response to PD-1 blockade immunotherapy J Peng, LS Xiao, ZY Dong, WW Li, KY Wang, DH Wu, L Liu Translational Cancer Research 7 (3), 2018 | 7 | 2018 |
| Deep learning to estimate durable clinical benefit and prognosis from patients with non-small cell lung cancer treated with PD-1/PD-L1 blockade J Peng, J Zhang, D Zou, L Xiao, H Ma, X Zhang, Y Li, L Han, B Xie Frontiers in Immunology 13, 960459, 2022 | 6 | 2022 |
| Organ-specific metastatic landscape dissects PD-(L) 1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice SC Ma, X Bai, XJ Guo, L Liu, LS Xiao, Y Lin, JL Tan, XT Cai, YX Wen, ... BMC medicine 20 (1), 120, 2022 | 6 | 2022 |
| Predictive value of the hepatic immune predictive index for patients with primary liver cancer treated with immune checkpoint inhibitors C Hong, HZ Dong, RN Li, HB Zhu, QM Li, H Cui, CY Hu, CY Huang, ... Digestive Diseases 41 (3), 422-430, 2023 | 4 | 2023 |
| Breakfast consumption frequency is associated with dyslipidemia: a retrospective cohort study of a working population Q Li, C Wu, P Ma, H Cui, R Li, C Hong, L Zeng, S Liao, L Xiao, L Liu, W Li Lipids in Health and Disease 21 (1), 33, 2022 | 4 | 2022 |
| Tea consumption is associated with an increased risk of hyperuricemia in an occupational population in Guangdong, China R Li, L Zeng, C Wu, P Ma, H Cui, L Chen, Q Li, C Hong, L Liu, L Xiao, W Li International Journal of General Medicine, 2747-2757, 2022 | 4 | 2022 |
| Clinical characteristics of patients with progressive and non-progressive coronavirus disease 2019: evidence from 365 hospitalised patients in Honghu and Nanchang, China Y Zhang, L Xiao, P Li, H Zhu, C Hu, WF Zhang, Q Sun, M Shen, S Liu, ... Frontiers in Medicine 7, 556818, 2020 | 4 | 2020 |
